Citation only
via Europe PMC
Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.
Urso D, Giannelli T, Tafuri B, Giannoni-Luza S, Gnoni V, Giugno A, Vilella D, Zecca C, De Blasi R, Nigro S, Aarsland D, Logroscino G.
Annals of neurology · 2026
Abstract
<h4>Objective</h4>Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and cognitive decline in patients with DLB remains underexplored.<h4>Methods</h4>Forty patients with DLB and 14 healthy controls (HCs) were included from the Centre for Neurodegenerative Diseases, University of Bari. Participants underwent neuropsychological evaluations, 3T magnetic resonance imaging (MRI) scans, and Alzheimer's biomarkers assessment. Patients with DLB were grouped by AD co-pathology using in vivo biomarkers. BF and hippocampal volumes and mean cortical thickness values were analyzed using analysis of covariance (ANCOVA), adjusted for age, sex, and total intracranial volume. Mediation analyses were conducted to examine the indirect effects of Alzheimer's pathology and BF atrophy on neurodegeneration (hippocampal volume and cortical thickness) and cognitive function (Mini-Mental State Examination [MMSE]).<h4>Results</h4>Patients with DLB exhibited significant BF atrophy compared with HCs (p < 0.001). AD co-pathology was associated with greater BF atrophy (p = 0.046) and reduced mean cortical thickness (p = 0.025). Significant correlations were found between BF volume and the pTAU<sub>181</sub>/Aβ<sub>1-42</sub> ratio (p = 0.009) and between BF volume and MMSE scores (p = 0.016). Mediation analysis revealed that BF atrophy mediated the relationship between the pTau/Aβ42 ratio and neurodegeneration, and that the BF has a direct association with cognitive impairment.<h4>Interpretation</h4>AD co-pathology in DLB exacerbates BF atrophy, correlating with cognitive decline. These results emphasize the need to consider AD co-pathology in evaluating neurodegeneration in DLB, suggesting future studies should explore targeted interventions to address this pathological overlap. ANN NEUROL 2026.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/ana.78357
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
D, U., T, G., B, T., S, G., V, G., A, G., D, V., C, Z., R, D.B., S, N., D, A., & G., L. (2026). Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. <em>Annals of neurology</em>. https://doi.org/10.1002/ana.78357
Vancouver
D U, T G, B T, S G, V G, A G, et al. Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. Annals of neurology. 2026. doi:10.1002/ana.78357.
BibTeX
@article{urso2026Alzhei,
title = {Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.},
author = {Urso D and Giannelli T and Tafuri B and Giannoni-Luza S and Gnoni V and Giugno A and Vilella D and Zecca C and De Blasi R and Nigro S and Aarsland D and Logroscino G.},
journal = {Annals of neurology},
year = {2026},
doi = {10.1002/ana.78357},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain 2017
Open access · CC-BY
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Annals of Clinical and Translational Neurology 2020
Open access · CC-BY
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
Neurology 2016
Open access · OA
Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia
2012
Preprint · OA
MRI Measures of Neurodegeneration as Biomarkers of Alzheimer's Disease
GeroScience 2025
Open access · CC-BY
Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment
University of Oviedo 2022
Open access · US-GOV